Genomics of Drug Sensitivity in Cancer |
FH535
|
Synonyms |
|
Targets |
PPARgamma, PPARdelta
|
Target pathway |
WNT signaling
|
PubCHEM ID |
3463933
|
Jsmol |
|
Download molecule |
3463933
|
PUBCHEM IUPAC INCHI |
InChI=1S/C13H10Cl2N2O4S/c1-8-6-10(17(18)19)3-5-12(8)16-22(20,21)13-7-9(14)2-4-11(13)15/h2-7,16H,1H3
|
Smiles |
ClC2(=C(S(=O)(=O)NC1(=C(C=C([N+](=O)[O-])C=C1)C))C=C(Cl)C=C2)
|
Cluster number |
40
|
calculated LogS |
-5,225
|
Molecular weight |
361,204
|
calculated LogP |
2,593
|
H-Acceptors |
6
|
H-Donors |
1
|
Ro5 violations |
0
|
Druglikeness |
-7,3487
|
DrugScore |
0,114756627994655
|
Mutagenic |
none
|
Tumorigenic |
high
|
Reproductive Effective |
high
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
0,942
|
Rat Acute Toxicity |
2,8792
|
Acute Oral Toxicity |
II
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
0,947
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
1,1584
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-4,2637
|